Cytoplasmic translocation of the retinoblastoma protein disrupts sarcomeric organization.
Cytoplasmic translocation of the retinoblastoma protein disrupts sarcomeric organization.
复制标题
作者:
Araki K;Kawauchi K;Hirata H;Yamamoto M;Taya Y
Skeletal muscle degeneration is a complication arising from a variety of chronic diseases including advanced cancer. Pro-inflammatory cytokine TNF-α plays a pivotal role in mediating cancer-related skeletal muscle degeneration. Here, we show a novel function for retinoblastoma protein (Rb), where Rb causes sarcomeric disorganization. In human skeletal muscle myotubes (HSMMs), up-regulation of cyclin-dependent kinase 4 (CDK4) and concomitant phosphorylation of Rb was induced by TNF-α treatment, resulting in the translocation of phosphorylated Rb to the cytoplasm. Moreover, induced expression of the nuclear exporting signal (NES)-fused form of Rb caused disruption of sarcomeric organization. We identified mammalian diaphanous-related formin 1 (mDia1), a potent actin nucleation factor, as a binding partner of cytoplasmic Rb and found that mDia1 helps maintain the structural integrity of the sarcomere. These results reveal a novel non-nuclear function for Rb and suggest a potential mechanism of TNF-α-induced disruption of sarcomeric organization. DOI: http://dx.doi.org/10.7554/eLife.01228.001 Skeletal muscles, such as the biceps and calves, are one of three main muscle groups in the body, and a range of chronic diseases—including cancer, heart disease and AIDS—can cause wasting and a loss of strength in these muscles. Many different cellular processes are known to be involved in the degeneration of skeletal muscle during illness. For example, in people suffering from cancer, the immune response produces large numbers of molecules called inflammatory cytokines to combat the cancer cells, and these molecules are thought to have a role in the breakdown of skeletal muscle. A cytokine called tumour necrosis factor alpha, or TNF-α for short, is thought to cause muscle damage, but the details of this process are not fully understood. One possibility is that TNF-α interacts with a protein called Rb—short for retinoblastoma protein—that suppresses the proliferation of cells that leads to cancer. However, if this protein is modified by a chemical process called phosphorylation, the Rb molecules will not be able to suppress the genes that lead to excessive cell growth. The hyperphosphorylation of Rb has been observed in many cancer cells, and it has been shown that high levels of TNF-α in cells results in Rb not working properly, but it has not been clear if faulty Rb also leads to the breakdown of skeletal muscle. Now Araki et al. provide evidence that the phosphorylation of Rb by TNF-α leads to skeletal muscle degeneration. Araki et al. found that in muscle cells that contain high concentrations of TNF-α, the Rb molecules move from the nuclei of the cells, where they interact with genes, to the cytoplasm, where they disrupt the formation of structural fibres. This means that Rb inhibits the ability of muscle cells to slide over one during contractions and relaxation, as happens in normal muscle tissue. If confirmed by further experiments, these results could lead to the development of new approaches for the treatment of skeletal muscle degeneration. DOI: http://dx.doi.org/10.7554/eLife.01228.002